Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Jan;13(1):72-7.
doi: 10.2450/2014.0324-13. Epub 2014 Jun 19.

Variant RH alleles and Rh immunisation in patients with sickle cell disease

Emilia Sippert  1 , Claudia R Fujita  2 , Debora Machado  1 , Glaucia Guelsin  1 , Ane C Gaspardi  1 , Jordão Pellegrino Jr  1 , Simone Gilli  1 , Sara S T O Saad  1 , Lilian Castilho  1
Affiliations
Clinical Trial

Variant RH alleles and Rh immunisation in patients with sickle cell disease

Emilia Sippert et al. Blood Transfus. 2015 Jan.

Abstract

Background: Alloimmunisation is a major complication in patients with sickle cell disease (SCD) receiving red blood cell (RBC) transfusions and despite provision of Rh phenotyped RBC units, Rh antibodies still occur. These antibodies in patients positive for the corresponding Rh antigen are considered autoantibodies in many cases but variant RH alleles found in SCD patients can also contribute to Rh alloimmunisation. In this study, we characterised variant RH alleles in 31 SCD patients who made antibodies to Rh antigens despite antigen-positive status and evaluated the clinical significance of the antibodies produced.

Materials and methods: RHD and RHCE BeadChip™ from BioArray Solutions and/or amplification and sequencing of exons were used to identify the RH variants. The serological features of all Rh antibodies in antigen-positive patients were analysed and the clinical significance of the antibodies was evaluated by retrospective analysis of the haemoglobin (Hb) levels before and after transfusion; the change from baseline pre-transfusion Hb and the percentage of HbS were also determined.

Results: We identified variant RH alleles in 31/48 (65%) of SCD patients with Rh antibodies. Molecular analyses revealed the presence of partial RHD alleles and variant RHCE alleles associated with altered C and e antigens. Five patients were compound heterozygotes for RHD and RHCE variants. Retrospective analysis showed that 42% of antibodies produced by the patients with RH variants were involved in delayed haemolytic transfusion reactions or decreased survival of transfused RBC.

Discussion: In this study, we found that Rh antibodies in SCD patients with RH variants can be clinically significant and, therefore, matching patients based on RH variants should be considered.

PubMed Disclaimer

References

    1. Tahhan RH, Holbrook LR, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34:562–9. - PubMed
    1. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anaemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94–8. - PubMed
    1. Castro O, Sandler SG, Houstoun-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002;42:683–90. - PubMed
    1. Chou ST, Westhoff CM. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2009;1:178–84. - PubMed
    1. Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013;122:1062–71. - PubMed

Publication types